SCHEMBL8561809

SCHEMBL8561809

Cc1cccc(C(=O)NC(CCC(=O)O)Oc2ccccc2)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UTS2R Q9UKP6 1/20 0.42
TDP1 Q9NUW8 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HTT P42858 1/20 0.40
PYGL P06737 1/20 0.40
CTSV O60911 1/20 0.39
CTSL P07711 1/20 0.39
CTSS P25774 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 2/20 0.38
POLB P06746 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
CRHBP P24387 1/20 0.37
FNTA P49354 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8561807 0.73 TDP1 (0.48) UTS2RTDP1PYGLCTSVCTSL
SCHEMBL25607328 0.72 NPC1 (0.51) UTS2RTDP1HTTNPC1RAB9A
SCHEMBL6358804 0.72 L3MBTL1 (0.46) UTS2RCTSVCTSLCTSSNPC1
SCHEMBL28554711 0.71 CTSV (0.45) UTS2RCTSVCTSLCTSSNPC1
SCHEMBL29732414 0.70 PYGL (0.54) TDP1KDM4EPYGLALDH1A1GAA
SCHEMBL9615846 0.70 PYGL (0.54) TDP1KDM4EPYGLALDH1A1GAA
SCHEMBL14606037 0.70 PYGL (0.54) TDP1KDM4EPYGLALDH1A1GAA
SCHEMBL5646798 0.69 ALDH1A1 (0.65) KDM4ENPC1ALDH1A1CYP1A2POLB
SCHEMBL14688351 0.68 NPC1 (0.51) UTS2RHTTNPC1RAB9AALDH1A1
SCHEMBL11502513 0.66 MTNR1A (0.56) KDM4ENPC1RAB9AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5994362-A ADMINISTERING FINASTERIDE AND CASODEX MERCK & CO., INC. (US) 1999-11-30 US disclosed
WO-1994015602-A1 COMBINATION METHOD FOR TREATING PATTERNED ALOPECIA WITH 17β-N-SUBSTITUTED-CARBAMOYL-4-AZA-5α-ANDROST-1-EN-3-ONES AND MINOXIDIL MERCK & CO., INC. (US) 1994-07-21 WO disclosed
EP-0576603-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC HYPERPLASIA, CONTAINING A 5 ALPHA-REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO. INC. (US) 1994-01-05 EP disclosed